Discussing Innovative Approaches in Gene Therapy for AMD by Targeting Inflammation, Establishing Retinal Bio-Factories as Long- Lasting Solutions

Time: 1:00 pm
day: Conference Day Two


  • Exploring cutting-edge research in gene therapy targeting inflammatory pathways associated with the complement system dysregulation in AMD
  • Discussing gene delivery vectors and viral vectors engineered to express therapeutic proteins locally in the retina, effectively turning it into a bio-factory
  • Overcoming the challenge of frequent, invasive injections by developing long-lasting gene therapies as a once-and-done treatment for late-stage AMD